The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
Solr Mobile Search
Page Title - Second Level
Publications and Digital Products
User account menu
Your browser is not supported
Switch to Chrome, Edge, Firefox or Safari
Main page content
TIP 63: Medications for Opioid Use Disorder Executive Summary
Publication ID
PEP21-02-01-003
Publication Date